Thus, we hypothesized that the PI polyamide targeting human TGF-β1 can suppress the development of HCC by inhibiting TGF-β1 transcriptional activity and examined its effects on the invasion and sphere formation of liver CSCs. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.